BriefCase - Central Pulmonary Embolism Triage

Aidoc
Aidoc's pulmonary embolism algorithm is a triage algorithm that alerts clinicians to the presence of one or more suspected pulmonary embolisms that are massive (high-risk), sub-massive (intermediate-risk) or low-risk acute pulmonary embolisms in the central segment. This algorithm is run on contrast enhanced CTs that are ordered for indications of a suspected pulmonary embolism.
Information source: Vendor
Last updated: February 16, 2025

General Information

General
Product name BriefCase - Central Pulmonary Embolism Triage
Company Aidoc
Subspeciality Chest
Modality CT
Disease targeted Central pulmonary embolism
Key-features Central pulmonary embolism triage, prioritisation, notification
Suggested use Before: adapting worklist order,
Before: flagging acute findings,
During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population Adults or transitional adolescents aged 18 or older
Input CTPA
Input format DICOM
Output Image review software, desktop application, alert notifications, worklist prioritisation
Output format Annotated images: DICOM Secondary Capture Worklist prioritisation: own application, HL7, API, bespoke integration
Technology
Integration Integration in standard reading environment (PACS), Integration RIS
Deployment Hybrid solution, Cloud based, Locally on dedicated hardware
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) BriefCase-Triage is a radiological computeraided triage and notification software indicated for use in the analysis of CTPA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of Central Pulmonary Embolism (Central PE).

Market

Market presence
On market since 10-2023
Distribution channels Change Healthcare, Merge Merative
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription
Based on Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers